Page 12 - Britain Eakin News Today

U.S. Patent and Trademark Office Director Kathi Vidal said Thursday she's had a busy first week steering the agency, which included working on updated guidance for Arthrex reviews and releasing public comments solicited on the so-called article of manufacture requirement for design patents.

The Patent Trial and Appeal Board has agreed to review two Vocalife LLC microphone patents, one of which a Texas jury ordered Amazon to pay $5 million for infringing, agreeing with challenger Google LLC that the patents are likely invalid.

The solicitor general has told the U.S. Supreme Court it should not entertain PersonalWeb Technologies' attempt to rein in the Federal Circuit's use of a 114-year-old doctrine that barred the software development company from suing Amazon's customers for patent infringement.

A Texas federal jury found on Friday that Daiichi Sankyo Co. Ltd. owes $41.8 million in damages because a breast cancer treatment medication it markets under the brand name Enhertu infringes a Seagen Inc. patent covering the delivery of a drug called Adcetris.

The Patent Trial and Appeal Board has agreed to review a Seagen Inc. antibody patent after the board previously used its discretion to reject two challenges from Daiichi Sankyo Inc. and AstraZeneca while a Texas federal jury on Friday found Daiichi willfully infringed the patent to the tune of $41.8 million.

A Federal Circuit panel weighed the latest installment in the ongoing Arthrex saga Wednesday, pressing the government on its argument that a longstanding U.S. Patent and Trademark Office directive authorizes Drew Hirshfeld, the interim leader of the agency, to implement the U.S. Supreme Court's Arthrex remedy.

With sharp critiques, the Federal Circuit on Thursday upheld a decision by the Patent Trial and Appeal Board's precedent-setting panel allowing DynaEnergetics to amend an oil drilling patent, while affirming the board's initial decision that the original claims were invalid.

Sportswear company Patagonia Inc. has sued the companies behind the "Assholes Live Forever" clothing brand for allegedly selling sweats, T-shirts, hoodies and beanies that use profane, ripped-off versions of Patagonia's trademark.

The U.S. Supreme Court on Monday denied Intel Corp.'s bid to strike down the Patent Trial and Appeal Board's controversial practice of denying patent challenges due to looming trials in district court, dealing another blow to the chorus of tech companies that have tried to kill the policy.

A month after AstraZeneca's Alexion Pharmaceuticals settled claims that its antibody product Ultomiris infringed patents held by Roche-owned rival Chugai Pharmaceutical Co. Ltd., Chugai's attorneys said Thursday the settlement netted their client $775 million.